Yuan, Y.-X.;                     Chen, R.-J.;                     Tu, G.-H.;                     Li, C.-Q.;                     Xu, L.-L.;                     Lu, Y.-L.;                     Wu, L.-X.    
        The SP1-SuperEnhancer-SPHK1 Axis Mediates Niraparib Resistance in TNBC. Pharmaceuticals 2025, 18, 1622.
    https://doi.org/10.3390/ph18111622
    AMA Style
    
                                Yuan Y-X,                                 Chen R-J,                                 Tu G-H,                                 Li C-Q,                                 Xu L-L,                                 Lu Y-L,                                 Wu L-X.        
                The SP1-SuperEnhancer-SPHK1 Axis Mediates Niraparib Resistance in TNBC. Pharmaceuticals. 2025; 18(11):1622.
        https://doi.org/10.3390/ph18111622
    
    Chicago/Turabian Style
    
                                Yuan, Yu-Xia,                                 Rui-Jia Chen,                                 Gui-Hui Tu,                                 Chao-Qi Li,                                 Long-Long Xu,                                 Yi-Ling Lu,                                 and Li-Xian Wu.        
                2025. "The SP1-SuperEnhancer-SPHK1 Axis Mediates Niraparib Resistance in TNBC" Pharmaceuticals 18, no. 11: 1622.
        https://doi.org/10.3390/ph18111622
    
    APA Style
    
                                Yuan, Y.-X.,                                 Chen, R.-J.,                                 Tu, G.-H.,                                 Li, C.-Q.,                                 Xu, L.-L.,                                 Lu, Y.-L.,                                 & Wu, L.-X.        
        
        (2025). The SP1-SuperEnhancer-SPHK1 Axis Mediates Niraparib Resistance in TNBC. Pharmaceuticals, 18(11), 1622.
        https://doi.org/10.3390/ph18111622